EODData

MEMBERSHIP REGISTER LOG IN

FRA, 1RT: NUFORMIX PLC LS -001

03 Sep 2025
LAST:

0.0010

CHANGE:
 0.00		OPEN:
0.0010		HIGH:
0.0010		ASK:
0.0000		VOLUME:
250K
CHG(%):
0.00		PREV:
0.0010		LOW:
0.0010		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 250.00100.00100.00100.0010250K
02 Sep 250.00100.00100.00100.0010250K
01 Sep 250.00100.00100.00100.0010250K
29 Aug 250.00100.00100.00100.0010250K
28 Aug 250.00100.00100.00100.0010250K
27 Aug 250.00100.00100.00100.0010250K
26 Aug 250.00100.00100.00100.0010250K
25 Aug 250.00100.00100.00100.0010250K
22 Aug 250.00100.00100.00100.0010250K
21 Aug 250.00100.00100.00100.0010250K

COMPANY PROFILE

Name:NUFORMIX PLC LS -001
About:Nuformix plc, together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. The company develops NXP001, which is in the Phase 1 stage for use in oncology supportive care; NXP002, which is in the pre-clinical stage for the treatment of idiopathic pulmonary fibrosis; and NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology. It has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:60 Gracechurch Street, London, United Kingdom, EC3V 0HR
Website:https://www.nuformix.com
ISIN:GB00BYW79Y38
LEI:2138003XG3H3I2J3BJ24

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.00
MA10:0.00
MA20:0.00
MA50:0.00
MA100:0.00
MA200:0.00
Week High:0.00
Week Low:0.00
Month High:0.00
Month Low:0.00
Year High:0.01
Year Low:0.00